According to Chembio Diagnostics's latest financial reports the company's current earnings (TTM) are -$23.45 M. an increase over its 2021 earnings that were of -$31.06 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 | -$23.45 M | -24.5% |
2021 | -$31.06 M | 41.39% |
2020 | -$21.97 M | 74.2% |
2019 | -$12.61 M | 65.02% |
2018 | -$7.64 M | 18.32% |
2017 | -$6.46 M | -14.48% |
2016 | -$7.56 M | 112.2% |
2015 | -$3.56 M | 129.53% |
2014 | -$1.56 M | -252.26% |
2013 | $1.01 M | -30.15% |
2012 | $1.45 M | 33.2% |
2011 | $1.09 M | -57.49% |
2010 | $2.57 M | 705.19% |
2009 | $0.31 M | -116.47% |
2008 | -$1.95 M | -32.53% |
2007 | -$2.88 M | -37.42% |
2006 | -$4.6 M | 39.43% |
2005 | -$3.3 M | |
2002 | -$0.05 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Trinity Biotech
TRIB | -$41.52 M | 77.08% | ๐ฎ๐ช Ireland |
QuidelOrtho QDEL | -$29.1 M | 24.12% | ๐บ๐ธ USA |
OraSure Technologies OSUR | $56.25 M | -339.96% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | -$0.86 B | 3,525.95% | ๐บ๐ธ USA |